Antitumor activity of C-methyl-β-D-ribofuranosyladenine nucleoside ribonucleotide reductase inhibitors

Journal of Medicinal Chemistry

Volumn 48, Issue 15, 2005, Pages 4983-4989

  Franchetti, Palmarisa ^a   Cappellacci, Loredana ^a   Pasqualini, Michela ^a   Petrelli, Riccardo ^a   Vita, Patrizia ^a   Jayaram, Hiremagalur N ^b   Horvath, Zsuzsanna ^c   Szekeres, Thomas ^c   Grifantini, Mario ^a  

^a UNIVERSITY OF CAMERINO   (Italy)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DERIVATIVE; C METHYL BETA DEXTRO RIBOFURANOSYLADENINE DERIVATIVE; CHLORINE; HYDROGEN; PURINE; PYRIMIDINE; RIBONUCLEOTIDE REDUCTASE INHIBITOR; RIBOSE; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CARCINOMA; COLON CARCINOMA; CONTROLLED STUDY; DRUG SCREENING; DRUG SYNTHESIS; ENZYME INHIBITION; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; PROMYELOCYTIC LEUKEMIA; REACTION ANALYSIS; STRUCTURE ACTIVITY RELATION; SUBSTITUTION REACTION;

ADENOSINE; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; RIBONUCLEOTIDE REDUCTASES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 22744446291     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm048944c     Document Type: Article

References (23)

1. Niitsu, N.; Ishii, Y.; Matsuda, A.; Honma, Y. Induction of differentiation of acute promyelocytic leukemia cells by a cytidine deaminase-resistant analogue of 1-β-D-arabinofuranosylcytosine, 1-(2-deoxy-2-methylene-β-D-erythro-pentofuranosyl)-cytosine. Cancer Res. 2001; 61, 178-185.
2. Sun, L. Q.; Li, Y. X.; Guillou, L.; Mirimanoff, R. O.; Coucke, P. A. Antitumor and radiosensitizing effects of (E)-2′-deoxy-2′- (fluoromethylene)cytidine, a novel inhibitor of ribpnucleoside diphosphate reductase, on human colon carcinoma xenografts in nude mice. Cancer Res. 1997, 57, 4023-4028.
3. Hattori, H.; Nozawa, E.; Iino, T.; Yoshimura, Y.; Shuto, S.; Shimamoto, Y.; Nomura, M.; Fukushima, M.; Tanaka, M.; Sasaki, T.; Matsuda, A. Nucleosides and nucleotides. 175. Structural requirements of the sugar moiety for the antitumor activities of new nucleoside antimetabolites, 1-(3-C-ethynyl-β-D- ribo-pentofuranosyl)cytosine and -uracile. J. Med. Chem. 1998, 41, 2892-2902.
4. Franchetti, P.; Cappellacci, L.; Marchetti, S.; Trincavelli, L.; Martini, C.; Mazzoni, M. R.; Lucacchini, A.; Grifantini, M. 2′-C-Methyl analogues of selective adenosine receptor agonists: Synthesis and binding studies. J. Med. Chem. 1998, 41, 1708-1715.
5. Cappellacci, L.; Barboni, G.; Palmieri, M.; Pasqualini, M.; Grifantini, M.; Costa, B.; Martini, C.; Franchetti, P. Ribose-modified nucleosides as ligands for adenosine receptors: Synthesis, conformational analysis, and biological evaluation of 1′-C-methyl adenosine analogues. J. Med. Chem. 2002, 45, 1196-1202.
6. Walton, E.; Jenkins, S. R.; Nutt, R. F.; Zimmerman, M.; Holly, F. W. Branched-chain sugar nucleosides. New type of biological active nucleoside. J. Am. Chem. Soc. 1966, 88, 4524-4525.
7. Nutt, R. F.; Dickinson, M. J.; Holly, F. W.; Walton, E. Branched-chain sugar nucleosides. III. 3′-C-Methyladenosine. J. Org. Chem. 1968, 33, 1789-1795.
8. Waga, T.; Nishizaki, T.; Miyakawa, I.; Ohrui, H.; Meguro, H. Studies on sugar-modified nucleosides. Part I. Synthesis of 4′-C-methylnucleosides. Biosci., Biotechnol., Biochem. 1993, 57, 1433-1438.
9. Griffon, J.-F.; Dukhan, D.; Pierra, C.; Benzaria, S.; Loi, A. G.; La Colla, P.; Sommadossi, J.-P.; Gosselin, G. 4′-C-Methyl-β-D- ribofuranosyl purine and pyrimidine nucleosides revisited. Nucleosides, Nucleotides Nucleic Acids 2003, 22, 707-709.
10. Ceruti, S.; Franceschi, C.; Barbieri, D.; Malorni, W.; Camurri, A.; Giammarioli, A. M.; Ambrosini, A.; Racagni, G.; Cattabeni, F.; Abbracchio, M. P. Apoptosis induced by 2-chloro-adenosine and 2-chloro-2′-deoxy-adenosine in a human astrocytoma cell line: differential mechanisms and possible clinical relevance. J. Neurosci. Res. 2000, 60, 388-400.
11. (a) Ong, S. P.; Nelson, L. S.; Hogenkamp, H. P. Synthesis of 3′-C-methyladenosine and 3′-C-methyluridine diphosphates and their interaction with the ribonucleoside diphosphate reductase from Corynebacterium nephridii. Biochemistry 1992, 31, 11210-11215.
12. (b) Ong, S. P.; McFarlan, S. C.; Hogenkamp, H. P. 2′-C- Methyladenosine and 2′-C-methyluridine 5′-diphosphates are mechanism-based inhibitors of ribonucleoside diphosphate reductase from Corynebacterium nephridii. Biochemistry 1993, 32, 11397-11404.
13. 6-alkyl subregion. J. Med. Chem. 1985, 28, 1636-1643.
14. 6-substituted 2-chloroadenosine at A1 and A2 adenosine receptors. J. Med. Chem. 1991, 34, 3388-3390.
15. Rosemeyer, H.; Toth, G.; Seela, F. Assignment of anomeric configuration of D-ribo-, arabino-, 2′-deoxyribo-, and 2′,3′- dideoxyribonucleosides by NOE difference spectroscopy. Nucleosides Nucleotides 1989, 8, 587-597.
16. Cappellacci, L.; Franchetti, P.; Pasqualini, M.; Petrelli, R.; Vita, P.; Lavecchia A.; Novellino, E.; Costa B.; Martini, C.; Klotz K.-N.; Grifantini M. Synthesis, biological evaluation and molecular modeling of ribose-modified adenosine analogues as adenosine receptor agonists. J. Med. Chem. 2005, 48, 1555-1562.
17. (a) Stubbe, J.; Ackles D. On the mechanism of ribonucleoside diphosphate reductase from Escherichia coli. Evidence for 3′-C-H bond cleavage. J. Biol. Chem. 1980, 265, 8027-8030.
18. (a) Eldrup, A. B.; Allerson, C. R.; Bennett, C. F.; Bera, S.; Bhat, B.; Bhat, N.; Bosserman, M. R.; Brooks, J.; Burlein, C.; Carrol, S. S.; Cook, P. D.; Getty, K. L.; MacCoss, M.; MacMasters, D. R.; Olsen, D. B.; Prakash, T. P.; Prhavc, M.; Song, Q.; Tomassini, J. E.; Xia, J. Structure-activity relationship of purine ribonucleosides for inhibition of hepatitis C virus RNA-dependent RNA polymerase. J. Med. Chem. 2004, 47, 2283-2295.
19. (b) Eldrup, A. B.; Prhavc, M.; Brooks, J.; Bhat, B.; Prakash, T. P.; Song, Q.; Bera, S.; Bhat, N.; Dande, P.; Cook, P. D.; Bennett, C. F.; Carroll, S. S.; Ball, R. G.; Bosserman, M.; Burlein, C.; Colwell, L. F.; Fay, J. F.; Flores, O. A.; Getty, K.; LaFemina, R. L.; Leone, J.; MacCoss, M.; McMasters, D. R.; Tomassini, J. E.; Von Langen, D.; Wolanski, B.; Olsen, D. B. Structure-activity relationship of heterobase-modified 2′-C-methyl ribonucleosides as inhibitors of hepatitis C virus RNA replication. J. Med. Chem. 2004, 47, 5284-5297.
20. Kalinichenko, E. N.; Beigel'man, L. N.; Mikhailov, S. N.; Mikhailopulo, I. A. Substrate specificity of adenosine deaminase. The role of methyl groups at 2′, 3′, and 5′-carbon atoms of adenosine. Bioorg. Khim. 1988, 14, 1157-1161.
21. Yalowitz, J. A.; Pankiewicz, K.; Patterson, S. E.; Jayaram, H. N. Cytotoxicity and cellular differentiation activity of methylenebis(phosphonate) analogues of tiazofurin and mycophenolic acid adenine dinucleotide in human cancer cell lines. Cancer Lett. 2002, 181, 31-38.
22. Garrett, C.; Santi, D. V. A Rapid and sensitive high-pressure liquid chromatography assay for deoxynucleoside triphosphates in cell extracts. Anal. Biochem. 1979, 99, 268-273.
23. Szekeres, T.; Gharehbaghi, K.; Fritzer, M.; Woody, M.; Srivastava, A.; van't Riet, B.; Jayaram, H. N.; Elford, H. L. Biochemical and antitumor activity of trimidox, a new inhibitor of ribonucleotide reductase. Cancer Chemother. Pharmacol. 1994, 34, 63-66.